Latest Information Update: 08 Oct 2012
At a glance
- Originator Sorbent Therapeutics
- Class Polymers
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Renal failure
Most Recent Events
- 08 Oct 2012 Discontinued - Phase-I for Renal failure in USA (unspecified route)